Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discontinuation of Buprenorphine Treatment for Opioid Use Disorder During the Coronavirus Disease-2019 Pandemic
Authors
Keywords
-
Journal
MEDICAL CARE
Volume 61, Issue 2, Pages 95-101
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-01-12
DOI
10.1097/mlr.0000000000001802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Opioid Use Disorder With Buprenorphine Among US Adolescents and Young Adults During the Early COVID-19 Pandemic
- (2022) Rachel H. Alinsky et al. JOURNAL OF ADOLESCENT HEALTH
- COVID-19 and the Drug Overdose Crisis: Uncovering the Deadliest Months in the United States, January‒July 2020
- (2021) Joseph Friedman et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- It will end in tiers: A strategy to include “dabblers” in the buprenorphine workforce after the X-waiver
- (2021) Brendan Saloner et al. Substance Abuse
- Common themes in early state policy responses to substance use disorder treatment during COVID-19
- (2021) Barbara Andraka-Christou et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Changes in US Medicaid Enrollment During the COVID-19 Pandemic
- (2021) Peggah Khorrami et al. JAMA Network Open
- Buprenorphine prescriber monthly patient caseloads: An examination of 6-year trajectories
- (2021) Irineo Cabreros et al. DRUG AND ALCOHOL DEPENDENCE
- Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US
- (2021) Bradley D. Stein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Changes in characteristics of drug overdose death trends during the COVID-19 pandemic
- (2021) Catherine DiGennaro et al. INTERNATIONAL JOURNAL OF DRUG POLICY
- Use of buprenorphine for those with employer-sponsored insurance during the initial phase of the COVID-19 pandemic
- (2021) Jonathan Cantor et al. JOURNAL OF SUBSTANCE ABUSE TREATMENT
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19
- (2020) G. Caleb Alexander et al. ANNALS OF INTERNAL MEDICINE
- Collision of the COVID-19 and Addiction Epidemics
- (2020) Nora D. Volkow ANNALS OF INTERNAL MEDICINE
- Opioid Policy Changes During the COVID-19 Pandemic - and Beyond
- (2020) Corey S. Davis et al. Journal of Addiction Medicine
- Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020
- (2020) Emma E. McGinty et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic
- (2020) Jessica Duncan Cance et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic
- (2020) Haiden A. Huskamp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Adoption of the 275-patient buprenorphine treatment waiver for treating opioid use disorder: A state-level longitudinal analysis
- (2019) Hannah K. Knudsen et al. Substance Abuse
- U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018
- (2019) Robin Ghertner DRUG AND ALCOHOL DEPENDENCE
- Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population
- (2017) Brendan Saloner et al. MEDICAL CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now